← Back to Search

Ultrasound-Guided IV Placement Techniques for Venous Access

N/A
Waitlist Available
Led By Ryan C Gibbons, MD
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Hemodynamically stable patients requiring placement of an USGPIV
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial compares two ways of placing IVs using ultrasound guidance.

Who is the study for?
This trial is for stable patients who need an ultrasound-guided peripheral IV placed. It's not open to those who are unstable or can't give consent.Check my eligibility
What is being tested?
The study is testing two different ways of placing IVs with ultrasound: the long axis approach and the short axis approach, to see which one works better.See study design
What are the potential side effects?
Since this trial involves standard procedures for IV placement, side effects may include discomfort at the insertion site, bruising, bleeding, or infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need an ultrasound-guided IV and my blood pressure is stable.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
First pass success
Number of attempts
Overall success
+1 more
Secondary outcome measures
Complications

Trial Design

2Treatment groups
Active Control
Group I: Long Axis approachActive Control1 Intervention
Utilize the longitudinal orientation when placing an USGPIV.
Group II: Short axis approachActive Control1 Intervention
Utilize the transverse orientation when placing an USGPIV.

Find a Location

Who is running the clinical trial?

Temple UniversityLead Sponsor
294 Previous Clinical Trials
81,700 Total Patients Enrolled
Ryan C Gibbons, MDPrincipal InvestigatorTemple University
2 Previous Clinical Trials
70 Total Patients Enrolled

Media Library

Intravenous access method Clinical Trial Eligibility Overview. Trial Name: NCT04234347 — N/A
Venous Access Research Study Groups: Long Axis approach, Short axis approach
Venous Access Clinical Trial 2023: Intravenous access method Highlights & Side Effects. Trial Name: NCT04234347 — N/A
Intravenous access method 2023 Treatment Timeline for Medical Study. Trial Name: NCT04234347 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can elderly people aged 85 and above participate in this experiment?

"As per the eligibility requirements of this clinical trial, participants should be aged 18 or above and no older than 99."

Answered by AI

Is it feasible for me to join this research initiative?

"Those eligible to join the study must have access to a vein and be between 18-99 years old. The total number of participants required is 98 people."

Answered by AI

Are there any openings left to join this research endeavor?

"Based on the clinicaltrials.gov listing, this trial is no longer enrolling patients; having been initially posted July 1st 2022 and last updated April 26th of the same year. Fortunately, there are other active studies seeking participants at present."

Answered by AI
~65 spots leftby Nov 2025